BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23755953)

  • 1. Impact of chemotherapy and radiotherapy for testicular germ cell tumors on spermatogenesis and sperm DNA: a multicenter prospective study from the CECOS network.
    Bujan L; Walschaerts M; Moinard N; Hennebicq S; Saias J; Brugnon F; Auger J; Berthaut I; Szerman E; Daudin M; Rives N
    Fertil Steril; 2013 Sep; 100(3):673-80. PubMed ID: 23755953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
    Bujan L; Walschaerts M; Brugnon F; Daudin M; Berthaut I; Auger J; Saias J; Szerman E; Moinard N; Rives N; Hennebicq S
    Fertil Steril; 2014 Sep; 102(3):667-674.e3. PubMed ID: 25044088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sperm aneuploidy after testicular cancer treatment: data from a prospective multicenter study performed within the French Centre d'Étude et de Conservation des Oeufs et du Sperme network.
    Rives N; Walschaerts M; Setif V; Hennebicq S; Saias J; Brugnon F; Auger J; Berthaut I; Szerman E; Daudin M; Bujan L
    Fertil Steril; 2017 Mar; 107(3):580-588.e1. PubMed ID: 28069184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regeneration of spermatogenesis after testicular cancer chemotherapy.
    Suzuki K; Yumura Y; Ogawa T; Saito K; Kinoshita Y; Noguchi K
    Urol Int; 2013; 91(4):445-50. PubMed ID: 24021744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: impact of chemotherapy and radiotherapy for testicular germ cell tumors on spermatogenesis and sperm DNA: a multicenter prospective study from the CECOS Network.
    Niederberger C
    J Urol; 2014 Jun; 191(6):1846. PubMed ID: 25280319
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of Hodgkin or non-Hodgkin lymphoma and their treatments on sperm aneuploidy: a prospective study by the French CECOS network.
    Martinez G; Walschaerts M; Le Mitouard M; Borye R; Thomas C; Auger J; Berthaut I; Brugnon F; Daudin M; Moinard N; Ravel C; Saias J; Szerman E; Rives N; Hennebicq S; Bujan L
    Fertil Steril; 2017 Feb; 107(2):341-350.e5. PubMed ID: 27810161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of chemotherapy with bleomycin, etoposide, and cis-platinum (BEP) on rat sperm chromatin remodeling, fecundity and testicular gene expression in the progeny.
    Maselli J; Hales BF; Robaire B
    Biol Reprod; 2013 Oct; 89(4):85. PubMed ID: 23986570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.
    Tryakin A; Fedyanin M; Kanagavel D; Fainstein I; Sergeev J; Polockij B; Matveev V; Zakharova T; Garin A; Tjulandin S
    Urology; 2011 Sep; 78(3):620-5. PubMed ID: 21764427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of zinc on rat sperm chromatin integrity involvement: DNA methylation, DNA fragmentation, ubiquitination and protamination after bleomycin etoposide and cis-platin treatment.
    Khadivi F; Razavi S; Hashemi F
    Theriogenology; 2020 Jan; 142():177-183. PubMed ID: 31600638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.
    Tandstad T; Dahl O; Cohn-Cedermark G; Cavallin-Stahl E; Stierner U; Solberg A; Langberg C; Bremnes RM; Laurell A; Wijkstrøm H; Klepp O
    J Clin Oncol; 2009 May; 27(13):2122-8. PubMed ID: 19307506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
    Haugnes HS; Laurell A; Stierner U; Bremnes RM; Dahl O; Cavallin-Ståhl E; Cohn-Cedermark G
    Acta Oncol; 2012 Feb; 51(2):168-76. PubMed ID: 22175254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the chemotherapy cocktail used to treat testicular cancer on the gene expression profile of germ cells from male Brown-Norway rats.
    Delbès G; Chan D; Pakarinen P; Trasler JM; Hales BF; Robaire B
    Biol Reprod; 2009 Feb; 80(2):320-7. PubMed ID: 18987330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
    J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer.
    Spermon JR; Ramos L; Wetzels AM; Sweep CG; Braat DD; Kiemeney LA; Witjes JA
    Hum Reprod; 2006 Jul; 21(7):1781-6. PubMed ID: 16601009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
    Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
    J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sperm DNA integrity in testicular cancer patients.
    Ståhl O; Eberhard J; Jepson K; Spano M; Cwikiel M; Cavallin-Ståhl E; Giwercman A
    Hum Reprod; 2006 Dec; 21(12):3199-205. PubMed ID: 16931803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversibility of the effects of subchronic exposure to the cancer chemotherapeutics bleomycin, etoposide, and cisplatin on spermatogenesis, fertility, and progeny outcome in the male rat.
    Marcon L; Hales BF; Robaire B
    J Androl; 2008; 29(4):408-17. PubMed ID: 18296477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Factors and Treatment Results After Bleomycin, Etoposide, and Cisplatin in Germ Cell Cancer: A Population-based Study.
    Kier MG; Lauritsen J; Mortensen MS; Bandak M; Andersen KK; Hansen MK; Agerbaek M; Holm NV; Dalton SO; Johansen C; Daugaard G
    Eur Urol; 2017 Feb; 71(2):290-298. PubMed ID: 27649970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.